Cartilage-Sparing Properties of Equine Omega Complete in an Organ Culture Model of Cartilage Inflammation

J Equine Vet Sci. 2023 Feb:121:104165. doi: 10.1016/j.jevs.2022.104165. Epub 2022 Nov 21.

Abstract

The purpose of this study was to determine anti-inflammatory and/or chondroprotective effects of Equine Omega Complete (EOC) on cartilage explants stimulated with lipopolysaccharide (LPS). Explants were aseptically prepared from the intercarpal joints of 17 market-weight pigs and placed in culture at 37°C for a total of 120 hours. For the final 96 hours, explants were conditioned with a simulated digestion extract of EOC (0, 36 or 180 μL/mL), and for the final 48 hours explants were stimulated with LPS (0 or 15µg/mL). Media was removed and replaced every 24 hours. Samples from the final 48 hours were analyzed for biomarkers of cartilage inflammation (prostaglandin E2 [PGE2] and nitric oxide [NO]) and cartilage structure (glycosaminoglycan [GAG]). At the end of the culture period cartilage explants were stained for an estimate of cell viability. Stimulation of unconditioned explants with LPS significantly increased media concentrations of PGE2, GAG and NO compared with that from unstimulated explants. LPS stimulation did not significantly affect cell viability. Both concentrations of EOC prevented significant LPS-stimulated cartilage release of GAG without impairing chondrocyte viability. No other effects of treatment were observed. These data provide evidence for a non-cytotoxic, chondroprotective effect of EOC in cartilage. This in vitro experiment supports the use of EOC in protecting against the detrimental effects of inflammation on cartilage structure.

Keywords: Arthritis; Cartilage; Equine; Nutraceuticals; Polyunsaturated fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Cartilage
  • Glycosaminoglycans / pharmacology
  • Glycosaminoglycans / therapeutic use
  • Horse Diseases* / drug therapy
  • Horses
  • Inflammation / drug therapy
  • Inflammation / veterinary
  • Lipopolysaccharides / pharmacology
  • Lipopolysaccharides / therapeutic use
  • Organ Culture Techniques / veterinary
  • Swine
  • Swine Diseases*

Substances

  • Lipopolysaccharides
  • Anti-Inflammatory Agents
  • Glycosaminoglycans